Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Severe restrictive lung disease in systemic sclerosis

V D Steen1, C Conte, G R Owens

  • 1University of Pittsburgh School of Medicine, Pennsylvania.

Arthritis and Rheumatism
|September 1, 1994
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Glucose-6-phosphate dehydrogenase deficiency detection using fluorocytometric assay: Evaluation after 1 year of clinical implementation.

Cytometry. Part B, Clinical cytometry·2024
Same author

Role of micronutrients in the symptoms of fibromyalgia: a review of the literature and analysis of an Italian female sample.

European review for medical and pharmacological sciences·2024
Same author

Incessant pericarditis following the second dose of SARS-CoV-2 mRNA vaccine successfully treated with anakinra: a case report.

European heart journal. Case reports·2022
Same author

Levosimendan for acute right heart failure in COVID-19: another arrow in our quiver?

European review for medical and pharmacological sciences·2022
Same author

Minimally Invasive Secondary Cytoreductive Surgery for Superficial Celiac and Cardio-Phrenic Isolated Nodal Recurrence of Ovarian Cancer.

Annals of surgical oncology·2022
Same author

An unusual case of death using a compacting machine.

La Clinica terapeutica·2021

Black men with early systemic sclerosis (SSc) and cardiac involvement face higher risks of severe lung disease. Early pulmonary function monitoring is crucial for identifying patients who may benefit from new therapies.

Area of Science:

  • Rheumatology
  • Pulmonology
  • Internal Medicine

Background:

  • Systemic sclerosis (SSc) is a multisystem autoimmune disease characterized by fibrosis, vascular abnormalities, and immune dysregulation.
  • Restrictive lung disease is a common and serious complication of SSc, significantly contributing to morbidity and mortality.
  • Identifying risk factors and progression patterns of severe restrictive lung disease in SSc is critical for patient management.

Purpose of the Study:

  • To identify risk factors associated with the development of severe restrictive lung disease in patients with SSc.
  • To determine the time of onset and rate of progression of lung function decline in SSc patients with severe restrictive lung disease.

Main Methods:

  • Patients from the University of Pittsburgh Scleroderma Databank were categorized based on their lowest forced vital capacity (FVC) percentage predicted.

Related Experiment Videos

  • Severe restrictive lung disease was defined as FVC < or = 50% predicted.
  • Serial pulmonary function test (PFT) results were analyzed to assess the rate of lung volume loss over time in patients with severe disease.

    • Main Results:

    • Of 890 SSc patients, 13% (n=116) had severe restrictive lung disease (FVC < or = 50% predicted).
    • Black race, male sex, early disease stage, and cardiac involvement were significantly associated with severe restrictive lung disease.
    • Rapid FVC decline (32% per year) was observed in the first two years of illness in patients with severe restrictive lung disease.

    Conclusions:

    • Black men with early SSc and cardiac involvement are at the highest risk for severe restrictive lung disease.
    • Early and careful monitoring of pulmonary function is essential, particularly during the initial years of SSc, when lung function decline is most rapid.
    • Disease subtype and specific autoantibodies did not differentiate between moderate and severe restrictive lung disease, highlighting the importance of clinical and demographic factors.